Obesity Featured Articles
-
Alzheimer's Trial Targeting Amyloid Beta Oligomers Sees Cost Savings, Patient Satisfaction With New Screening
8/29/2025
Acumen Pharmaceuticals' Eric Siemers, MD, discusses their novel Alzheimer's disease screening method and trial design for investigational drug sabirnetug that keeps both the clinical site and patient experience in mind.
-
Insuring Global Clinical Trials: Navigating Risks Across Borders
8/28/2025
Foreign clinical trials insurance is indispensable. Learn its features, its benefits, and why it's needed.
-
Clinical Safety Services In FSP Models
8/27/2025
Selecting the right functional service provider (FSP) for safety services is fundamental to protecting patients and requires a resilient, strategic partnership that enhances trial integrity and outcomes.
-
Navigating The Complexities Of Planning And Executing Multiregional Clinical Trials
8/27/2025
Plan your first overseas study or expand an established pipeline; with the help of strategic insights to navigate complexities, maximize investment, and position new therapies for international success.
-
Why New Zealand Is Emerging As A Clinical Trial Hub
8/27/2025
New Zealand is rapidly emerging as a premier destination for clinical research, offering a unique combination of regulatory agility, scientific expertise, and cost efficiency.
-
Why More Biotechs Are Starting Trials In Australia
8/27/2025
Why are so many U.S. biotechs heading to Australia for their first-in-human trials? Speed, cost, and simplicity. In our latest piece, Megan Robertson and Tina Soulis break down how sponsors can move from protocol to first patient in just a few months—while saving money and generating data regulators will accept worldwide.
-
Misconceptions About Cancer Clinical Trials And How To Overcome Them
8/27/2025
Medical oncologist Wasif Saif, MD, MBBS, discusses many of the misconceptions held by patients and clinicians about cancer clinical trials.
-
Sustainable Clinical Trials Through eClinical Innovation
8/26/2025
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
-
Honoring Patient Altruism: Empowering Clinical Trial Participants With Better Technology
8/26/2025
Simplifying participation honors patient altruism, improves engagement, and strengthens the quality of trial data, ultimately advancing medical innovation.
-
Paying Trial Participants With Prepaid Cards? You Need To Hear This
8/25/2025
Examine the complexities of participant payments in clinical trials with a focus on prepaid cards and other payment methods.